MiniMed CEO has 4,809 shares withheld for taxes

MiniMed Group, Inc. Chief Executive Officer Dallara Que reported a routine tax-related share disposition.

Accepted by SEC EDGAR 03/27/2026 - 04:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MiniMed Group, Inc. Chief Executive Officer Dallara Que reported a routine tax-related share disposition. On this Form 4, 4,809 shares of Common Stock were withheld by the company at $16.31 per share to cover income tax obligations tied to vesting RSUs. After this withholding, Que directly holds 616,754 shares, and the filing notes that this total includes shares to be issued upon future RSU vesting.

Insider Trade Summary

Exercise Price or Tax Liability: 4,809 shares

Exercise Price or Tax Liability 1 txn

Insider Dallara Que

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	4,809	$16.31	$78K

Holdings After Transaction: Common Stock — 616,754 shares (Direct)

Holdings Before and After: Common Stock, 621,563 to 616,754 shares (Direct)

Footnotes (2)

1. F1. Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
2. F2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MiniMed Group (MMED) report for CEO Dallara Que?

MiniMed Group reported that CEO Dallara Que had 4,809 common shares withheld to cover income tax obligations from vesting RSUs. This was a tax-withholding disposition, not an open-market purchase or sale, and is a routine administrative transaction.

Was the MiniMed Group (MMED) CEO’s Form 4 transaction a market sale of shares?

No, the Form 4 shows no open-market sale. The 4,809 shares of MiniMed Group common stock were withheld by the company to satisfy income tax and remittance obligations related to RSU vesting, rather than sold by the CEO in the open market.

How many MiniMed Group (MMED) shares does CEO Dallara Que hold after this filing?

Following the tax-withholding transaction, CEO Dallara Que directly holds 616,754 shares of MiniMed Group common stock. This figure also includes shares that will be issued upon the vesting of one or more Restricted Stock Units disclosed in the filing.

What does the tax-withholding code “F” mean in the MiniMed Group (MMED) Form 4?

The “F” code on the Form 4 indicates shares were disposed of to pay taxes or exercise costs. For MiniMed Group, 4,809 shares were withheld by the company to satisfy income tax obligations arising from the vesting and net settlement of RSUs.

Does the MiniMed Group (MMED) Form 4 indicate any option exercises or derivative transactions?

No derivative exercises are reported in this Form 4. The derivativeSummary shows no remaining derivative transactions in this filing, and the only reported activity is a single tax-withholding disposition of 4,809 common shares related to RSU vesting.

How significant is the MiniMed Group (MMED) CEO’s tax-withholding transaction for investors?

The transaction is administrative, reflecting 4,809 shares withheld for taxes on RSU vesting. Such F-code tax-withholding events typically do not signal a change in the CEO’s view of MiniMed Group stock, especially with 616,754 shares still held directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dallara Que

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		F		4,809(1)	D	$16.31	616,754(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").

2. Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)